Parliament Panel Criticizes Delay Of India Drugs Policy
This article was originally published in PharmAsia News
Executive Summary
A Parliament panel is critical of India's drug department for delaying the final version of the National Pharmaceutical Policy 2006. The policy is intended to lower the price of drugs through expanded price controls. The Parliamentary Standing Committee on Chemical and Fertiliser noted the department had strongly endorsed the proposed policy in an annual report, but said the agency had done little since, holding only three meetings on the matter. The committee said part of the budget intended to follow up on the policy remains unspent while the policy review continues without end. (Click here for more